Home
Live Updates
Brixton Biosciences Nabs $33M to Advance Novel Pain Therapies : comparemela.com
Brixton Biosciences Nabs $33M to Advance Novel Pain Therapies
Brixton Biosciences, a clinical-stage life sciences company focused on innovative pain treatments raises $33M in Series B funding led by...
Related Keywords
Massachusetts ,
United States ,
Sameer Sabir ,
Brixton Biosciences ,
Michael Fishman ,
Sv Health Investors ,
Catalyst Health Ventures ,
Sparta Group ,
Centric Pain Solutions ,
Medtronic ,
Brixton Biosciences Secures ,
Advance Novel Pain Therapies ,
Chief Executive Officer ,
Should Know ,
Schooner Capital ,
Excelestar Ventures ,
Catalyst Health ,
Chief Medical ,
Reggie Groves ,
Pioneering Patient Centric Pain ,
Massachusetts General Brigham ,
Neural Ice ,
Biosciences Secures ,
Breakthrough Device Designation ,
comparemela.com © 2020. All Rights Reserved.